Inventor · disambiguated record
Donald J. P. Pinto
Also filed as: PINTO DONALD · PINTO DONALD J · PINTO DONALD J P · PINTO DONALD JOSEPH PHILIP
52 granted patents·2,091 citations·filing 1992–2020
99Inventor score
Files withBRISTOL MYERS SQUIBB CO26BRISTOL MYERS SQUIBB PHARMA CO9DU PONT PHARM CO9DU PONT MERCK PHARMA4PINTO DONALD J P2
Top patents by PatentIndex Score
52 records- 0198US6187797B1Phenyl-isoxazoles as factor XA InhibitorsDU PONT PHARM CO·Filed 1997·Granted Feb 13, 2001·171 cites·27 claims
- 0298US6020357ANitrogen containing heteroaromatics as factor Xa inhibitorsDU PONT PHARM CO·Filed 1997·Granted Feb 1, 2000·353 cites·72 claims
- 0398US5998424AInhibitors of factor Xa with a neutral P1 specificity groupDU PONT PHARM CO·Filed 1998·Granted Dec 7, 1999·163 cites·23 claims
- 0497US6548525B2Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Apr 15, 2003·125 cites·17 claims
- 0597US6339099B1Guanidine mimics as factor Xa inhibitorsDU PONT PHARM CO·Filed 1998·Granted Jan 15, 2002·128 cites·40 claims
- 0697US6060491A6-membered aromatics as factor Xa inhibitorsDU PONT PHARM CO·Filed 1998·Granted May 9, 2000·107 cites·15 claims
- 0797US5593994AProstaglandin synthase inhibitorsDU PONT MERCK PHARMA·Filed 1994·Granted Jan 14, 1997·251 cites·13 claims
- 0896US6548512B1Nitrogen containing heteroaromatics as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Apr 15, 2003·75 cites·52 claims
- 0996US6191159B1Disubstituted pyrazolines and triazolines as factor Xa inhibitorsDU PONT PHARM CO·Filed 1999·Granted Feb 20, 2001·73 cites·45 claims
- 1095US6569874B1Thiazoles as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted May 27, 2003·40 cites·45 claims
- 1194US9192607B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Nov 24, 2015·7 cites·11 claims
- 1294US6998408B26-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Feb 14, 2006·68 cites·30 claims
- 1393US9000172B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Apr 7, 2015·7 cites·19 claims
- 1492US6960595B25-6 to 5-7 Heterobicycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 1, 2005·38 cites·35 claims
- 1591US6599926B2Heteroaryl-phenyl substituted factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 29, 2003·37 cites·21 claims
- 1690US7338963B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Mar 4, 2008·9 cites·14 claims
- 1790US6750225B21,4,5,6-tetrahydropyrazolo-[3,4,-c]-pyridin-7-ones useful as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMS CO·Filed 2002·Granted Jun 15, 2004·35 cites·65 claims
- 1890US6436985B2Disubstituted pyrazolines and triazolines as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Aug 20, 2002·21 cites·36 claims
- 1990US6426346B16-membered aromatics as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Jul 30, 2002·34 cites·12 claims
- 2090US6271237B1Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitorsDU PONT PHARM CO·Filed 1998·Granted Aug 7, 2001·57 cites·42 claims
- 2189US9944625B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 17, 2018·3 cites·14 claims
- 2288US7691846B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Apr 6, 2010·6 cites·8 claims
- 2387US6506771B2Heteroaryl-phenyl heterobicyclic factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jan 14, 2003·35 cites·36 claims
- 2486US5849736AIsoxazoline and isoxazole fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1995·Granted Dec 15, 1998·70 cites·31 claims
- 2584US9108951B2Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Aug 18, 2015·5 cites·6 claims
- 2684US7960411B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jun 14, 2011·4 cites·7 claims
- 2784US6057342AAmidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereofDUPONT PHARMACEUTICAL CO·Filed 1997·Granted May 2, 2000·44 cites·19 claims
- 2883US6962935B2Oxygen or sulfur containing heteroaromatics as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Nov 8, 2005·10 cites·36 claims
- 2983US6706730B21,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Mar 16, 2004·15 cites·5 claims
- 3082US8188120B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsPINTO DONALD J P·Filed 2011·Granted May 29, 2012·3 cites·7 claims
- 3181US5244917ASubstituted naphthofurans as anti-inflammatory agentsDU PONT MERCK PHARMA·Filed 1992·Granted Sep 14, 1993·22 cites·12 claims
- 3279US10676477B2Factor XIa macrocycle inhibitors bearing a non-aromatic P2' groupBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 9, 2020·2 cites·12 claims
- 3379US9447110B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 20, 2016·1 cites·1 claims
- 3477US10000466B2Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 19, 2018·1 cites·5 claims
- 3574US10336730B2Substituted glycine derived FXIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jul 2, 2019·1 cites·10 claims
- 3674US5939418AIsoxazoline, isothiazoline and pyrazoline factor Xa inhibitorsDU PONT MERCK PHARMA·Filed 1996·Granted Aug 17, 1999·19 cites·12 claims
- 3773US10611776B2Spiroheptane salicylamides and related compounds as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 7, 2020·1 cites·17 claims
- 3871US6114328AIsoxazoline and isoxazole fibrogen receptor antagonistsDU PONT PHARM CO·Filed 1997·Granted Sep 5, 2000·27 cites·49 claims
- 3969US10208021B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 19, 2019·0 cites·3 claims
- 4066US9738655B2Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 22, 2017·1 cites·15 claims
- 4166US5932586AProstaglandin synthase inhibitorsDU PONT PHARM CO·Filed 1996·Granted Aug 3, 1999·21 cites·9 claims
- 4259US7250415B21,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 31, 2007·1 cites·16 claims
- 4358US10829501B2Spiroheptane salicylamides and related compounds as inhibitors of ROCKBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 10, 2020·0 cites·5 claims
- 4458US9725435B2Substituted 4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 8, 2017·0 cites·5 claims
- 4555US9394276B2Substituted 1,2,3,4-tetrahydro-2,6-naphthyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 19, 2016·0 cites·5 claims
- 4649US8410155B2Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIA inhibitorsPINTO DONALD J P·Filed 2007·Granted Apr 2, 2013·0 cites·15 claims
- 4747US9315519B2Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 19, 2016·0 cites·18 claims
- 4845US9403774B2Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 2, 2016·0 cites·17 claims
- 4944US11306081B2Phenylacetamides as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 19, 2022·0 cites·14 claims
- 5044US9079929B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Jul 14, 2015·0 cites·11 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →